Compare Cart
  • Japanese
  • Korean
  • Traditional Chinese
  • Simplified Chinese
Cover Image
Market Research Report
Product code 
1023272

Large Molecule Bioanalytical Testing Services Market Size, Share & Trends Analysis Report By Phase (Preclinical, Clinical), By Test Type (PK, PD), By Type, By Therapeutic Area, By End User, And Segment Forecasts, 2021 - 2028
Published: | Grand View Research, Inc. | 137 Pages | Delivery time: 2-10 business days

Price

Back to Top
Large Molecule Bioanalytical Testing Services Market Size, Share & Trends Analysis Report By Phase (Preclinical, Clinical), By Test Type (PK, PD), By Type, By Therapeutic Area, By End User, And Segment Forecasts, 2021 - 2028
Published: August 9, 2021
Grand View Research, Inc.
Content info: 137 Pages
Delivery time: 2-10 business days
  • Description
  • Table of Contents
  • List of Tables

Large Molecule Bioanalytical Testing Services Market Growth & Trends:

The global large molecule bioanalytical testing services market size is expected to reach USD 3.0 billion by 2028, according to a new study by Grand View Research, Inc. It is expected to expand at a CAGR of 9.5% from 2021 to 2028. The major factor attributing to market growth is the increased application of bioanalytical testing in clinical trials of biomarkers, large molecules, and others.

Rising prevalence of HIV, infectious disease, and others has led to increasing demand for bioanalytical testing services globally. Moreover, increasing government initiatives to control the outbreak of various infectious diseases such as Corona and Ebola virus is anticipated to offer more opportunities for the market. Hence, the market is expected to grow over the assessment period.

The market is expected to witness lucrative growth during the forecast period due to increased research activities and the presence of a huge pipeline of peptides, biologics, and amino acids based molecules. Additionally, bioanalysis of large molecules requires skilled professionals with innovative analytical instruments and infrastructure. These services are readily offered by bioanalytical testing service providers and are likely to propel the growth of the market during the assessment period.

North America accounted for the highest share in 2019. The U.S. holds the highest market share due to the increasing prevalence of various chronic diseases and the growing adoption of large molecule therapeutics as an alternative for small molecules.

For example, according to International Diabetes Federation Report 2019, around 49.0 million geriatric population in the U.S. has diabetes and this has led to increasing requests for bioanalysis of the novel (large molecule compounds) peptide therapeutics such as glucagon-like peptide 1(GLP-1). Due to this reason, the market is expected to show growth over the forecast period. In addition, the presence of major players in the region contributed to market growth.

Large Molecule Bioanalytical Testing Services Market Report Highlights:

  • By type, the clinical segment held the largest market share in 2019 owing to increasing demand for clinical trials due to the rising prevalence of various infectious diseases
  • Bioavailability held the largest market share of 20.9% in 2019 owing to increasing adoption in generic drug manufacturing
  • The oncology segment held the largest revenue share due to the increasing prevalence of cancer globally
  • The U.S. is expected to witness the fastest growth over the forecast period owing to the growing adoption of advanced therapeutic techniques in the country.
Product Code: GVR-4-68038-979-1

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Phase
    • 1.1.2. Type
    • 1.1.3. Test Type
    • 1.1.4. Therapeutic Area
    • 1.1.5. End User
    • 1.1.6. Regional scope
    • 1.1.7. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1: Understanding the market dynamics
    • 1.9.2. Objective 2: Understanding the market estimates and forecasts
    • 1.9.3. Objective 3: Understanding the attributes such as strategy framework, competitor categorization
    • 1.9.4. Objective 4: Understanding the key service scopes to conclude on the market size

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Large Molecule Bioanalytical Testing Services Market Variables, Trends & Scope

  • 3.1. Market Lineage outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Product Pipeline Analysis, by Service
  • 3.4. Market Dynamics
    • 3.4.1. Market Driver Analysis
      • 3.4.1.1. Increasing focus on the analytical testing
      • 3.4.1.2. Growing R&D expenditure in the pharmaceutical and biopharmaceutical industries
      • 3.4.1.3. Rising demand for outsourcing of analytical testing
    • 3.4.2. Market Restraint Analysis
      • 3.4.2.1. Compliance issues while outsourcing
    • 3.4.3. Industry Challenges
      • 3.4.3.1. Managing the relationships
  • 3.5. Large Molecule Bioanalytical Testing Services: Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier Power
      • 3.5.1.2. Buyer Power
      • 3.5.1.3. Substitution Threat
      • 3.5.1.4. Threat from new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political Landscape
      • 3.5.2.2. Environmental Landscape
      • 3.5.2.3. Social Landscape
      • 3.5.2.4. Technology Landscape
      • 3.5.2.5. Legal Landscape
    • 3.5.3. Major Deals & Strategic Alliances Analysis
    • 3.5.4. Impact of Covi -19

Chapter 4. Large Molecule Bioanalytical Testing Services Market: Segment Analysis, by Phase, 2016 - 2028 (USD Million)

  • 4.1. Definitions & Scope
  • 4.2. Service market share analysis, 2020 & 2028
  • 4.3. Segment Dashboard
  • 4.4. Global Large Molecule Bioanalytical Testing Services Market, by Phase, 2016 to 2027
  • 4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
    • 4.5.1. Preclinical
      • 4.5.1.1. With Antibody
      • 4.5.1.2. Without Antibody (ELISA Based Assay)
    • 4.5.2. Clinical
      • 4.5.2.1. With Antibody
      • 4.5.2.2. Without Antibody (ELISA Based Assay)

Chapter 5. Large Molecule Bioanalytical Testing Services Market: Segment Analysis, by Type, 2016 - 2028 (USD Million)

  • 5.1. Definitions & Scope
  • 5.2. Service market share analysis, 2020 & 2028
  • 5.3. Segment Dashboard
  • 5.4. Global Large Molecule Bioanalytical Testing Services Market, by Type, 2016 to 2028
  • 5.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
    • 5.5.1. Pharmacokinetics
    • 5.5.2. ADA
    • 5.5.3. Others

Chapter 6. Large Molecule Bioanalytical Testing Services Market: Segment Analysis, by Test Type, 2016 - 2028 (USD Million)

  • 6.1. Definitions & Scope
  • 6.2. Service market share analysis, 2020 & 2028
  • 6.3. Segment Dashboard
  • 6.4. Global Large Molecule Bioanalytical Testing Services Market, by Test Type, 2016 to 2028
  • 6.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
    • 6.5.1. ADME
    • 6.5.2. PK
    • 6.5.3. PD
    • 6.5.4. Bioavailability
    • 6.5.5. Bioequivalence
    • 6.5.6. Other Tests

Chapter 7. Large Molecule Bioanalytical Testing Services Market: Segment Analysis, by Therapeutic Area, 2016 - 2028 (USD Million)

  • 7.1. Definitions & Scope
  • 7.2. Service market share analysis, 2020 & 2028
  • 7.3. Segment Dashboard
  • 7.4. Global Large Molecule Bioanalytical Testing Services Market, by Therapeutic Area, 2016 to 2027
  • 7.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
    • 7.5.1. Oncology
    • 7.5.2. Infectious Diseases
    • 7.5.3. Cardiology
    • 7.5.4. Neurology
    • 7.5.5. Others

Chapter 8. Large Molecule Bioanalytical Testing Services Market: Segment Analysis, by End User, 2016 - 2028 (USD Million)

  • 8.1. Definitions & Scope
  • 8.2. Service market share analysis, 2020 & 2028
  • 8.3. Segment Dashboard
  • 8.4. Global Large Molecule Bioanalytical Testing Services Market, by End User, 2016 to 2028
  • 8.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
    • 8.5.1. SMEs
      • 8.5.1.1. CROs & CMOs
      • 8.5.1.2. Sponsor Organizations
      • 8.5.1.3. Others (Academic Institute, etc.)
    • 8.5.2. Large Firms
      • 8.5.2.1. CROs & CMOs
      • 8.5.2.2. Sponsor Organizations
      • 8.5.2.3. Others (Academic Institute, etc.)

Chapter 9. Large Molecule Bioanalytical Testing Services: Regional Market Analysis, 2016 - 2028 (USD Million)

  • 9.1. Definitions & Scope
  • 9.2. Regional Market Share Analysis, 2020 & 2028
  • 9.3. Regional Market Dashboard
  • 9.4. Regional Market Snapshot
  • 9.5. Regional Market Share, 2020
  • 9.6. Market Size, & Forecasts, and Trend Analysis, 2016 to 2028:
  • 9.7. North America
    • 9.7.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
    • 9.7.2. Market estimates and forecast, by Phase, 2016 - 2028 (USD Million)
    • 9.7.3. Market estimates and forecast, by Type, 2016 - 2028 (USD Million)
    • 9.7.4. Market estimates and forecast, By Test Type, 2016 - 2028 (USD Million)
    • 9.7.5. Market estimates and forecast, By Therapeutic Area, 2016 - 2028 (USD Million)
    • 9.7.6. Market estimates and forecast, By End User, 2016 - 2028 (USD Million)
    • 9.7.7. The U.S.
      • 9.7.7.1. Market estimates and forecast, by Phase, 2016 - 2028 (USD Million)
      • 9.7.7.2. Market estimates and forecast, by Type, 2016 - 2028 (USD Million)
      • 9.7.7.3. Market estimates and forecast, by Test Type, 2016 - 2028 (USD Million)
      • 9.7.7.4. Market estimates and forecast, by Therapeutic Area, 2016 - 2028 (USD Million)
      • 9.7.7.5. Market estimates and forecast, by End User, 2016 - 2028 (USD Million)
    • 9.7.8. Canada
      • 9.7.8.1. Market estimates and forecast, by Phase, 2016 - 2028 (USD Million)
      • 9.7.8.2. Market estimates and forecast, by Type, 2016 - 2028 (USD Million)
      • 9.7.8.3. Market estimates and forecast, by Test Type, 2016 - 2028 (USD Million)
      • 9.7.8.4. Market estimates and forecast, by Therapeutic Area, 2016 - 2028 (USD Million)
      • 9.7.8.5. Market estimates and forecast, by End User, 2016 - 2028 (USD Million)
  • 9.8. Europe
    • 9.8.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
    • 9.8.2. Market estimates and forecast, by Phase, 2016 - 2028 (USD Million)
    • 9.8.3. Market estimates and forecast, by Type, 2016 - 2028 (USD Million)
    • 9.8.4. Market estimates and forecast, By Test Type, 2016 - 2028 (USD Million)
    • 9.8.5. Market estimates and forecast, By Therapeutic Area, 2016 - 2028 (USD Million)
    • 9.8.6. Market estimates and forecast, By End User, 2016 - 2028 (USD Million)
    • 9.8.7. Germany
      • 9.8.7.1. Market estimates and forecast, by Phase, 2016 - 2028 (USD Million)
      • 9.8.7.2. Market estimates and forecast, by Type, 2016 - 2028 (USD Million)
      • 9.8.7.3. Market estimates and forecast, by Test Type, 2016 - 2028 (USD Million)
      • 9.8.7.4. Market estimates and forecast, by Therapeutic Area, 2016 - 2028 (USD Million)
      • 9.8.7.5. Market estimates and forecast, by End User, 2016 - 2028 (USD Million)
    • 9.8.8. The U.K.
      • 9.8.8.1. Market estimates and forecast, by Phase, 2016 - 2028 (USD Million)
      • 9.8.8.2. Market estimates and forecast, by Type, 2016 - 2028 (USD Million)
      • 9.8.8.3. Market estimates and forecast, by Test Type, 2016 - 2028 (USD Million)
      • 9.8.8.4. Market estimates and forecast, by Therapeutic Area, 2016 - 2028 (USD Million)
      • 9.8.8.5. Market estimates and forecast, by End User, 2016 - 2028 (USD Million)
    • 9.8.9. France
      • 9.8.9.1. Market estimates and forecast, by Phase, 2016 - 2028 (USD Million)
      • 9.8.9.2. Market estimates and forecast, by Type, 2016 - 2028 (USD Million)
      • 9.8.9.3. Market estimates and forecast, by Test Type, 2016 - 2028 (USD Million)
      • 9.8.9.4. Market estimates and forecast, by Therapeutic Area, 2016 - 2028 (USD Million)
      • 9.8.9.5. Market estimates and forecast, by End User, 2016 - 2028 (USD Million)
    • 9.8.10. Italy
      • 9.8.10.1. Market estimates and forecast, by Phase, 2016 - 2028 (USD Million)
      • 9.8.10.2. Market estimates and forecast, by Type, 2016 - 2028 (USD Million)
      • 9.8.10.3. Market estimates and forecast, by Test Type, 2016 - 2028 (USD Million)
      • 9.8.10.4. Market estimates and forecast, by Therapeutic Area, 2016 - 2028 (USD Million)
      • 9.8.10.5. Market estimates and forecast, by End User, 2016 - 2028 (USD Million)
    • 9.8.11. Spain
    • 9.8.12. Market estimates and forecast, by Phase, 2016 - 2028 (USD Million)
    • 9.8.13. Market estimates and forecast, by Type, 2016 - 2028 (USD Million)
    • 9.8.14. Market estimates and forecast, by Test Type, 2016 - 2028 (USD Million)
    • 9.8.15. Market estimates and forecast, by Therapeutic Area, 2016 - 2028 (USD Million)
    • 9.8.16. Market estimates and forecast, by End User, 2016 - 2028 (USD Million)
  • 9.9. Asia Pacific
    • 9.9.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
    • 9.9.2. Market estimates and forecast, by Phase, 2016 - 2028 (USD Million)
    • 9.9.3. Market estimates and forecast, by Type, 2016 - 2028 (USD Million)
    • 9.9.4. Market estimates and forecast, by Test Type, 2016 - 2028 (USD Million)
    • 9.9.5. Market estimates and forecast, by Therapeutic Area, 2016 - 2028 (USD Million)
    • 9.9.6. Market estimates and forecast, by End User, 2016 - 2028 (USD Million)
    • 9.9.7. China
      • 9.9.7.1. Market estimates and forecast, by Phase, 2016 - 2028 (USD Million)
      • 9.9.7.2. Market estimates and forecast, by Type, 2016 - 2028 (USD Million)
      • 9.9.7.3. Market estimates and forecast, by Test Type, 2016 - 2028 (USD Million)
      • 9.9.7.4. Market estimates and forecast, by Therapeutic Area, 2016 - 2028 (USD Million)
      • 9.9.7.5. Market estimates and forecast, by End User, 2016 - 2028 (USD Million)
    • 9.9.8. Japan
      • 9.9.8.1. Market estimates and forecast, by Phase, 2016 - 2028 (USD Million)
      • 9.9.8.2. Market estimates and forecast, by Type, 2016 - 2028 (USD Million)
      • 9.9.8.3. Market estimates and forecast, by Test Type, 2016 - 2028 (USD Million)
      • 9.9.8.4. Market estimates and forecast, by Therapeutic Area, 2016 - 2028 (USD Million)
      • 9.9.8.5. Market estimates and forecast, by End User, 2016 - 2028 (USD Million)
    • 9.9.9. India
      • 9.9.9.1. Market estimates and forecast, by Phase, 2016 - 2028 (USD Million)
      • 9.9.9.2. Market estimates and forecast, by Type, 2016 - 2028 (USD Million)
      • 9.9.9.3. Market estimates and forecast, by Test Type, 2016 - 2028 (USD Million)
      • 9.9.9.4. Market estimates and forecast, by Therapeutic Are, 2016 - 2028 (USD Million)
      • 9.9.9.5. Market estimates and forecast, by End User, 2016 - 2028 (USD Million)
    • 9.9.10. South Korea
      • 9.9.10.1. Market estimates and forecast, by Phase, 2016 - 2028 (USD Million)
      • 9.9.10.2. Market estimates and forecast, by Type, 2016 - 2028 (USD Million)
      • 9.9.10.3. Market estimates and forecast, by Test Type, 2016 - 2028 (USD Million)
      • 9.9.10.4. Market estimates and forecast, by Therapeutic Area, 2016 - 2028 (USD Million)
      • 9.9.10.5. Market estimates and forecast, by End User, 2016 - 2028 (USD Million)
    • 9.9.11. Thailand
      • 9.9.11.1. Market estimates and forecast, by Phase, 2016 - 2028 (USD Million)
      • 9.9.11.2. Market estimates and forecast, by Type, 2016 - 2028 (USD Million)
      • 9.9.11.3. Market estimates and forecast, by Test Type, 2016 - 2028 (USD Million)
      • 9.9.11.4. Market estimates and forecast, by Therapeutic Area, 2016 - 2028 (USD Million)
      • 9.9.11.5. Market estimates and forecast, by End User, 2016 - 2028 (USD Million)
  • 9.10. Latin America
      • 9.10.1.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
      • 9.10.1.2. Market estimates and forecast, by Phase, 2016 - 2028 (USD Million)
      • 9.10.1.3. Market estimates and forecast, by Type, 2016 - 2028 (USD Million)
      • 9.10.1.4. Market estimates and forecast, by Test Type, 2016 - 2028 (USD Million)
      • 9.10.1.5. Market estimates and forecast, by Therapeutic Area, 2016 - 2028 (USD Million)
      • 9.10.1.6. Market estimates and forecast, by End User, 2016 - 2028 (USD Million)
    • 9.10.2. Brazil
      • 9.10.2.1. Market estimates and forecast, by Phase, 2016 - 2028 (USD Million)
      • 9.10.2.2. Market estimates and forecast, by Type, 2016 - 2028 (USD Million)
      • 9.10.2.3. Market estimates and forecast, by Test Type, 2016 - 2028 (USD Million)
      • 9.10.2.4. Market estimates and forecast, by Therapeutic Area, 2016 - 2028 (USD Million)
      • 9.10.2.5. Market estimates and forecast, by End User, 2016 - 2028 (USD Million)
    • 9.10.3. Mexico
      • 9.10.3.1. Market estimates and forecast, by Phase, 2016 - 2028 (USD Million)
      • 9.10.3.2. Market estimates and forecast, by Type, 2016 - 2028 (USD Million)
      • 9.10.3.3. Market estimates and forecast, by Test Type, 2016 - 2028 (USD Million)
      • 9.10.3.4. Market estimates and forecast, by Therapeutic Area, 2016 - 2028 (USD Million)
      • 9.10.3.5. Market estimates and forecast, by End User, 2016 - 2028 (USD Million)
    • 9.10.4. Argentina
      • 9.10.4.1. Market estimates and forecast, by Phase, 2016 - 2028 (USD Million)
      • 9.10.4.2. Market estimates and forecast, by Type, 2016 - 2028 (USD Million)
      • 9.10.4.3. Market estimates and forecast, by Test Type, 2016 - 2028 (USD Million)
      • 9.10.4.4. Market estimates and forecast, by Therapeutic Area, 2016 - 2028 (USD Million)
      • 9.10.4.5. Market estimates and forecast, by End User, 2016 - 2028 (USD Million)
    • 9.10.5. Colombia
      • 9.10.5.1. Market estimates and forecast, by Phase, 2016 - 2028 (USD Million)
      • 9.10.5.2. Market estimates and forecast, by Type, 2016 - 2028 (USD Million)
      • 9.10.5.3. Market estimates and forecast, by Test Type, 2016 - 2027(USD Million)
      • 9.10.5.4. Market estimates and forecast, by Therapeutic Area, 2016 - 2027 (USD Million)
      • 9.10.5.5. Market estimates and forecast, by End User, 2016 - 2028 (USD Million)
    • 9.10.6. Middle East and Africa
      • 9.10.6.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
      • 9.10.6.2. Market estimates and forecast, by Phase, 2016 - 2028 (USD Million)
      • 9.10.6.3. Market estimates and forecast, by Type, 2016 - 2028 (USD Million)
      • 9.10.6.4. Market estimates and forecast, by Test Type, 2016 - 2028 (USD Million)
      • 9.10.6.5. Market estimates and forecast, by Therapeutic Area, 2016 - 2028 (USD Million)
      • 9.10.6.6. Market estimates and forecast, by End User, 2016 - 2028 (USD Million)
    • 9.10.7. South Africa
      • 9.10.7.1. Market estimates and forecast, by Phase, 2016 - 2028 (USD Million)
      • 9.10.7.2. Market estimates and forecast, by Type, 2016 - 2028 (USD Million)
      • 9.10.7.3. Market estimates and forecast, by Test Type, 2016 - 2028 (USD Million)
      • 9.10.7.4. Market estimates and forecast, by Therapeutic Area, 2016 - 2028 (USD Million)
      • 9.10.7.5. Market estimates and forecast, by End User, 2016 - 2028 (USD Million)
    • 9.10.8. Saudi Arabia
      • 9.10.8.1. Market estimates and forecast, by Phase, 2016 - 2028 (USD Million)
      • 9.10.8.2. Market estimates and forecast, by Type, 2016 - 2028 (USD Million)
      • 9.10.8.3. Market estimates and forecast, by Test Type, 2016 - 2028 (USD Million)
      • 9.10.8.4. Market estimates and forecast, by Therapeutic Area, 2016 - 2028 (USD Million)
      • 9.10.8.5. Market estimates and forecast, by End User, 2016 - 2028 (USD Million)
    • 9.10.9. UAE
      • 9.10.9.1. Market estimates and forecast, by Phase, 2016 - 2028 (USD Million)
      • 9.10.9.2. Market estimates and forecast, by Type, 2016 - 2028 (USD Million)
      • 9.10.9.3. Market estimates and forecast, by Test Type, 2016 - 2028 (USD Million)
      • 9.10.9.4. Market estimates and forecast, by Therapeutic Area, 2016 - 2028 (USD Million)
      • 9.10.9.5. Market estimates and forecast, by End User, 2016 - 2028 (USD Million)

Chapter 10. Large Molecule Bioanalytical Testing Services - Competitive Analysis

  • 10.1. Key companies profiled
    • 10.1.1. Covance, Inc.
      • 10.1.1.1. Company Overview
      • 10.1.1.2. Financial Performance
      • 10.1.1.3. Product Benchmarking
      • 10.1.1.4. Strategic Initiatives
    • 10.1.2. IQVIA
      • 10.1.2.1. Company Overview
      • 10.1.2.2. Financial Performance
      • 10.1.2.3. Product Benchmarking
      • 10.1.2.4. Strategic Initiatives
    • 10.1.3. Syneos Health
      • 10.1.3.1. Company Overview
      • 10.1.3.2. Financial Performance
      • 10.1.3.3. Product Benchmarking
      • 10.1.3.4. Strategic Initiatives
    • 10.1.4. Charles River Laboratory International
      • 10.1.4.1. Company Overview
      • 10.1.4.2. Financial Performance
      • 10.1.4.3. Product Benchmarking
      • 10.1.4.4. Strategic Initiatives
    • 10.1.5. ICON Plc
      • 10.1.5.1. Company Overview
      • 10.1.5.2. Financial Performance
      • 10.1.5.3. Product Benchmarking
      • 10.1.5.4. Strategic Initiatives
    • 10.1.6. SGS SA
      • 10.1.6.1. Company Overview
      • 10.1.6.2. Financial Performance
      • 10.1.6.3. Product Benchmarking
      • 10.1.6.4. Strategic Initiatives
    • 10.1.7. Toxikon
      • 10.1.7.1. Company Overview
      • 10.1.7.2. Financial Performance
      • 10.1.7.3. Product Benchmarking
      • 10.1.7.4. Strategic Initiatives
    • 10.1.8. Intertek Group plc
      • 10.1.8.1. Company Overview
      • 10.1.8.2. Financial Performance
      • 10.1.8.3. Product Benchmarking
      • 10.1.8.4. Strategic Initiatives
    • 10.1.9. Pace Analytical Services LLC
      • 10.1.9.1. Company Overview
      • 10.1.9.2. Financial Performance
      • 10.1.9.3. Product Benchmarking
      • 10.1.9.4. Strategic Initiatives
    • 10.1.10. PPD, INC.
      • 10.1.10.1. Company Overview
      • 10.1.10.2. Financial Performance
      • 10.1.10.3. Product Benchmarking
      • 10.1.10.4. Strategic Initiative

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Large Molecule Bioanalytical Testing Services Market, By Region 2016 - 2028 (USD Million)
  • Table 4 Global Large Molecule Bioanalytical Testing Services Market, By Phase, 2016 - 2028 (USD Million)
  • Table 5 Global Large Molecule Bioanalytical Testing Services Market, By Type, 2016 - 2028 (USD Million)
  • Table 6 Global Large Molecule Bioanalytical Testing Services Market, By Test Type, 2016 - 2028 (USD Million)
  • Table 7 Global Large Molecule Bioanalytical Testing Services Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 8 Global Large Molecule Bioanalytical Testing Services Market, By End User, 2016 - 2028 (USD Million)
  • Table 9 North America Large Molecule Bioanalytical Testing Services Market, By Country, 2016 - 2028 (USD Million)
  • Table 10 North America Large Molecule Bioanalytical Testing Services Market, By Phase, 2016 - 2028 (USD Million)
  • Table 11 North America Large Molecule Bioanalytical Testing Services Market, By Type, 2016 - 2028 (USD Million)
  • Table 12 North America Large Molecule Bioanalytical Testing Services Market, By Test Type, 2016 - 2028 (USD Million)
  • Table 13 North America Large Molecule Bioanalytical Testing Services Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 14 North America Large Molecule Bioanalytical Testing Services Market, By End User, 2016 - 2028 (USD Million)
  • Table 15 The U.S. Large Molecule Bioanalytical Testing Services Market, By Phase, 2016 - 2028 (USD Million)
  • Table 16 The U.S. Large Molecule Bioanalytical Testing Services Market, By Type, 2016 - 2028 (USD Million)
  • Table 17 The U.S. Large Molecule Bioanalytical Testing Services Market, By Test Type, 2016 - 2028 (USD Million)
  • Table 18 The U.S. Large Molecule Bioanalytical Testing Services Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 19 The U.S. Large Molecule Bioanalytical Testing Services Market, By End User, 2016 - 2028 (USD Million)
  • Table 20 Canada Large Molecule Bioanalytical Testing Services Market, By Phase, 2016 - 2028 (USD Million)
  • Table 21 Canada Large Molecule Bioanalytical Testing Services Market, By Type, 2016 - 2028 (USD Million)
  • Table 22 Canada Large Molecule Bioanalytical Testing Services Market, By Test Type, 2016 - 2028 (USD Million)
  • Table 23 Canada Large Molecule Bioanalytical Testing Services Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 24 Canada Large Molecule Bioanalytical Testing Services Market, By End User, 2016 - 2028 (USD Million)
  • Table 25 Europe Large Molecule Bioanalytical Testing Services Market, By Country, 2016 - 2028 (USD Million)
  • Table 26 Europe Large Molecule Bioanalytical Testing Services Market, By Phase, 2016 - 2028 (USD Million)
  • Table 27 Europe Large Molecule Bioanalytical Testing Services Market, By Type, 2016 - 2028 (USD Million)
  • Table 28 Europe Large Molecule Bioanalytical Testing Services Market, By Test Type, 2016 - 2028 (USD Million)
  • Table 29 Europe Large Molecule Bioanalytical Testing Services Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 30 Europe Large Molecule Bioanalytical Testing Services Market, By End User, 2016 - 2028 (USD Million)
  • Table 31 The U.K. Large Molecule Bioanalytical Testing Services Market, By Phase, 2016 - 2028 (USD Million)
  • Table 32 The U.K. Large Molecule Bioanalytical Testing Services Market, By Type, 2016 - 2028 (USD Million)
  • Table 33 The U.K. Large Molecule Bioanalytical Testing Services Market, By Test Type, 2016 - 2028 (USD Million)
  • Table 34 The U.K. Large Molecule Bioanalytical Testing Services Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 35 The U.K. Large Molecule Bioanalytical Testing Services Market, By End User, 2016 - 2028 (USD Million)
  • Table 36 Germany Large Molecule Bioanalytical Testing Services Market, By Phase, 2016 - 2028 (USD Million)
  • Table 37 Germany Large Molecule Bioanalytical Testing Services Market, By Type, 2016 - 2028 (USD Million)
  • Table 38 Germany Large Molecule Bioanalytical Testing Services Market, By Test Type, 2016 - 2028 (USD Million)
  • Table 39 Germany Large Molecule Bioanalytical Testing Services Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 40 Germany Large Molecule Bioanalytical Testing Services Market, By End User, 2016 - 2028 (USD Million)
  • Table 41 France Large Molecule Bioanalytical Testing Services Market, By Phase, 2016 - 2028 (USD Million)
  • Table 42 France Large Molecule Bioanalytical Testing Services Market, By Type, 2016 - 2028 (USD Million)
  • Table 43 France Large Molecule Bioanalytical Testing Services Market, By Test Type, 2016 - 2028 (USD Million)
  • Table 44 France Large Molecule Bioanalytical Testing Services Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 45 France Large Molecule Bioanalytical Testing Services Market, By End User, 2016 - 2028 (USD Million)
  • Table 46 Italy Large Molecule Bioanalytical Testing Services Market, By Phase, 2016 - 2028 (USD Million)
  • Table 47 Italy Large Molecule Bioanalytical Testing Services Market, By Type, 2016 - 2028 (USD Million)
  • Table 48 Italy Large Molecule Bioanalytical Testing Services Market, By Test Type, 2016 - 2028 (USD Million)
  • Table 49 Italy Large Molecule Bioanalytical Testing Services Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 50 Italy Large Molecule Bioanalytical Testing Services Market, By End User, 2016 - 2028 (USD Million)
  • Table 51 Spain Large Molecule Bioanalytical Testing Services Market, By Phase, 2016 - 2028 (USD Million)
  • Table 52 Spain Large Molecule Bioanalytical Testing Services Market, By Type, 2016 - 2028 (USD Million)
  • Table 53 Spain Large Molecule Bioanalytical Testing Services Market, By Test Type, 2016 - 2028 (USD Million)
  • Table 54 Spain Large Molecule Bioanalytical Testing Services Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 55 Spain Large Molecule Bioanalytical Testing Services Market, By End User, 2016 - 2028 (USD Million)
  • Table 56 Asia Pacific Large Molecule Bioanalytical Testing Services Market, By Phase, 2016 - 2028 (USD Million)
  • Table 57 Asia Pacific Large Molecule Bioanalytical Testing Services Market, By Type, 2016 - 2028 (USD Million)
  • Table 58 Asia Pacific Large Molecule Bioanalytical Testing Services Market, By Test Type, 2016 - 2028 (USD Million)
  • Table 59 Asia Pacific Large Molecule Bioanalytical Testing Services Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 60 Asia Pacific Large Molecule Bioanalytical Testing Services Market, By End User, 2016 - 2028 (USD Million)
  • Table 61 China Large Molecule Bioanalytical Testing Services Market, By Phase, 2016 - 2028 (USD Million)
  • Table 62 China Large Molecule Bioanalytical Testing Services Market, By Type, 2016 - 2028 (USD Million)
  • Table 63 China Large Molecule Bioanalytical Testing Services Market, By Test Type, 2016 - 2028 (USD Million)
  • Table 64 China Large Molecule Bioanalytical Testing Services Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 65 China Large Molecule Bioanalytical Testing Services Market, By End User, 2016 - 2028 (USD Million)
  • Table 66 Japan Large Molecule Bioanalytical Testing Services Market, By Phase, 2016 - 2028 (USD Million)
  • Table 67 Japan Large Molecule Bioanalytical Testing Services Market, By Type, 2016 - 2028 (USD Million)
  • Table 68 Japan Large Molecule Bioanalytical Testing Services Market, By Test Type, 2016 - 2028 (USD Million)
  • Table 69 Japan Large Molecule Bioanalytical Testing Services Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 70 Japan Large Molecule Bioanalytical Testing Services Market, By End User, 2016 - 2028 (USD Million)
  • Table 71 India Large Molecule Bioanalytical Testing Services Market, By Phase, 2016 - 2028 (USD Million)
  • Table 72 India Large Molecule Bioanalytical Testing Services Market, By Type, 2016 - 2028 (USD Million)
  • Table 73 India Large Molecule Bioanalytical Testing Services Market, By Test Type, 2016 - 2028 (USD Million)
  • Table 74 India Large Molecule Bioanalytical Testing Services Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 75 India Large Molecule Bioanalytical Testing Services Market, By End User, 2016 - 2028 (USD Million)
  • Table 76 South Korea Large Molecule Bioanalytical Testing Services Market, By Phase, 2016 - 2028 (USD Million)
  • Table 77 South Korea Large Molecule Bioanalytical Testing Services Market, By Type, 2016 - 2028 (USD Million)
  • Table 78 South Korea Large Molecule Bioanalytical Testing Services Market, By Test Type, 2016 - 2028 (USD Million)
  • Table 79 South Korea Large Molecule Bioanalytical Testing Services Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 80 South Korea Large Molecule Bioanalytical Testing Services Market, By End User, 2016 - 2028 (USD Million)
  • Table 81 Thailand Large Molecule Bioanalytical Testing Services Market, By Phase, 2016 - 2028 (USD Million)
  • Table 82 Thailand Large Molecule Bioanalytical Testing Services Market, By Type, 2016 - 2028 (USD Million)
  • Table 83 Thailand Large Molecule Bioanalytical Testing Services Market, By Test Type, 2016 - 2028 (USD Million)
  • Table 84 Thailand Large Molecule Bioanalytical Testing Services Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 85 Thailand Large Molecule Bioanalytical Testing Services Market, By End User, 2016 - 2028 (USD Million)
  • Table 86 Latin America Large Molecule Bioanalytical Testing Services Market, By Phase, 2016 - 2028 (USD Million)
  • Table 87 Latin America Large Molecule Bioanalytical Testing Services Market, By Type, 2016 - 2028 (USD Million)
  • Table 88 Latin America Large Molecule Bioanalytical Testing Services Market, By Test Type, 2016 - 2028 (USD Million)
  • Table 89 Latin America Large Molecule Bioanalytical Testing Services Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 90 Latin America Large Molecule Bioanalytical Testing Services Market, By End User, 2016 - 2028 (USD Million)
  • Table 91 Brazil Large Molecule Bioanalytical Testing Services Market, By Phase, 2016 - 2028 (USD Million)
  • Table 92 Brazil Large Molecule Bioanalytical Testing Services Market, By Type, 2016 - 2028 (USD Million)
  • Table 93 Brazil Large Molecule Bioanalytical Testing Services Market, By Test Type, 2016 - 2028 (USD Million)
  • Table 94 Brazil America Large Molecule Bioanalytical Testing Services Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 95 Brazil America Large Molecule Bioanalytical Testing Services Market, By End User, 2016 - 2028 (USD Million)
  • Table 96 Mexico Large Molecule Bioanalytical Testing Services Market, By Phase, 2016 - 2028 (USD Million)
  • Table 97 Mexico Large Molecule Bioanalytical Testing Services Market, By Type, 2016 - 2028 (USD Million)
  • Table 98 Mexico Large Molecule Bioanalytical Testing Services Market, By Test Type, 2016 - 2028 (USD Million)
  • Table 99 Mexico America Large Molecule Bioanalytical Testing Services Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 100 Mexico America Large Molecule Bioanalytical Testing Services Market, By End User, 2016 - 2028 (USD Million)
  • Table 101 Argentina Large Molecule Bioanalytical Testing Services Market, By Phase, 2016 - 2028 (USD Million)
  • Table 102 Argentina Large Molecule Bioanalytical Testing Services Market, By Type, 2016 - 2028 (USD Million)
  • Table 103 Argentina Large Molecule Bioanalytical Testing Services Market, By Test Type, 2016 - 2028 (USD Million)
  • Table 104 Argentina America Large Molecule Bioanalytical Testing Services Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 105 Argentina America Large Molecule Bioanalytical Testing Services Market, By End User, 2016 - 2028 (USD Million)
  • Table 106 Colombia Large Molecule Bioanalytical Testing Services Market, By Phase, 2016 - 2028 (USD Million)
  • Table 107 Colombia Large Molecule Bioanalytical Testing Services Market, By Type, 2016 - 2028 (USD Million)
  • Table 108 Colombia Large Molecule Bioanalytical Testing Services Market, By Test Type, 2016 - 2028 (USD Million)
  • Table 109 Colombia America Large Molecule Bioanalytical Testing Services Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 110 Colombia America Large Molecule Bioanalytical Testing Services Market, By End User, 2016 - 2028 (USD Million)
  • Table 111 Middle East and Africa Large Molecule Bioanalytical Testing Services Market, By Phase, 2016 - 2028 (USD Million)
  • Table 112 Middle East and Africa Large Molecule Bioanalytical Testing Services Market, By Type, 2016 - 2028 (USD Million)
  • Table 113 Middle East and Africa Large Molecule Bioanalytical Testing Services Market, By Test Type, 2016 - 2028 (USD Million)
  • Table 114 Middle East and Africa America Large Molecule Bioanalytical Testing Services Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 115 Middle East and Africa America Large Molecule Bioanalytical Testing Services Market, By End User, 2016 - 2028 (USD Million)
  • Table 116 South Africa Large Molecule Bioanalytical Testing Services Market, By Phase, 2016 - 2028 (USD Million)
  • Table 117 South Africa Large Molecule Bioanalytical Testing Services Market, By Type, 2016 - 2028 (USD Million)
  • Table 118 South Africa Large Molecule Bioanalytical Testing Services Market, By Test Type, 2016 - 2028 (USD Million)
  • Table 119 South Africa America Large Molecule Bioanalytical Testing Services Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 120 South Africa America Large Molecule Bioanalytical Testing Services Market, By End User, 2016 - 2028 (USD Million)
  • Table 121 Saudi Arabia Large Molecule Bioanalytical Testing Services Market, By Phase, 2016 - 2028 (USD Million)
  • Table 122 Saudi Arabia Large Molecule Bioanalytical Testing Services Market, By Type, 2016 - 2028 (USD Million)
  • Table 123 Saudi Arabia Large Molecule Bioanalytical Testing Services Market, By Test Type, 2016 - 2028 (USD Million)
  • Table 124 Saudi Arabia America Large Molecule Bioanalytical Testing Services Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 125 Saudi Arabia America Large Molecule Bioanalytical Testing Services Market, By End User, 2016 - 2028 (USD Million)
  • Table 126 UAE Large Molecule Bioanalytical Testing Services Market, By Phase, 2016 - 2028 (USD Million)
  • Table 127 UAE Large Molecule Bioanalytical Testing Services Market, By Type, 2016 - 2028 (USD Million)
  • Table 128 UAE Large Molecule Bioanalytical Testing Services Market, By Test Type, 2016 - 2028 (USD Million)
  • Table 129 UAE America Large Molecule Bioanalytical Testing Services Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 130 UAE America Large Molecule Bioanalytical Testing Services Market, By End User, 2016 - 2028 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value - chain - based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Large molecule bioanalytical testing services market: Market snapshot
  • Fig. 9 Large molecule bioanalytical testing services market: Market segmentation
  • Fig. 10 Large molecule bioanalytical testing services market strategy framework
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Large molecule bioanalytical testing services market driver impact
  • Fig. 14 Large molecule bioanalytical testing services market restraint impact
  • Fig. 15 Large molecule bioanalytical testing services market porter's five forces analysis
  • Fig. 16 Large molecule bioanalytical testing services market PESTEL analysis
  • Fig. 17 Large molecule bioanalytical testing services market segment dashboard
  • Fig. 18 Large molecule bioanalytical testing services market: Phase movement Analysis
  • Fig. 19 Preclinical estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 20 Clinical estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 21 Large molecule bioanalytical testing services market: Type movement Analysis
  • Fig. 22 Pharmacokinetic estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 23 ADA estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 24 Others estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 25 Large molecule bioanalytical testing services market: Test Type movement Analysis
  • Fig. 26 ADME estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 27 PK estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 28 PD estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 29 Bioavailability estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 30 Bioequivalence estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 31 Others estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 32 Large molecule bioanalytical testing services market: Therapeutic area movement Analysis
  • Fig. 33 Oncology estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 34 Infectious disease estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 35 Cardiology estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 36 Neurology estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 37 Others estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 38 Large molecule bioanalytical testing services market: End User movement Analysis
  • Fig. 39 SMEs estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 40 Large firm estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 41 Global Large Molecule Bioanalytical Testing Services Market: Regional outlook and key takeaways
  • Fig. 42 Global market share, by region
  • Fig. 43 North America market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 44 The U.S. market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 45 Canada market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 46 Europe market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 47 The U.K. market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 48 Germany market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 49 France market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 50 Italy market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 51 Spain market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 52 Asia Pacific market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 53 China market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 54 Japan market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 55 India market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 56 South Korea market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 57 Thailand market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 58 Latin America market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 59 Brazil market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 60 Mexico market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 61 Argentina market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 62 Colombia market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 63 Middle East and Africa. market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 64 South Africa market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 65 Saudi Arabia market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 66 UAE market estimates and forecast, 2016 - 2028 (USD Million)